Literature DB >> 25510388

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule.

Shamez N Ladhani1, Nick J Andrews2, Pauline Waight3, Bassam Hallis4, Mary Matheson4, Anna England4, Helen Findlow5, Xilian Bai5, Ray Borrow5, Polly Burbidge6, Emma Pearce6, David Goldblatt6, Elizabeth Miller3.   

Abstract

An open, non-randomised study was undertaken in England during 2011-12 to evaluate vaccine antibody responses in infants after completion of the routine primary infant immunisation schedule, which included two doses of meningococcal group C (MenC) conjugate (MCC) vaccine at 3 and 4 months. Any of the three licensed MCC vaccines could be used for either dose, depending on local availability. Healthy term infants registered at participating general practices (GPs) in Hertfordshire and Gloucestershire, UK, were recruited prospectively to provide a single blood sample four weeks after primary immunisation, which was administered by the GP surgery. Vaccination history was obtained at blood sampling. MenC serum bactericidal antibody (SBA) and IgG antibodies against Haemophilus influenzae b (Hib), pertussis toxin (PT), diphtheria toxoid (DT), tetanus toxoid (TT) and thirteen pneumococcal serotypes were analysed according to MCC vaccines received. MenC SBA responses differed significantly (P<0.001) according to MCC vaccine schedule as follows: MenC SBA geometric mean titres (GMTs) were significantly lower in infants receiving a diphtheria cross-reacting material-conjugated MCC (MCC-CRM) vaccine followed by TT-conjugated MCC (MCC-TT) vaccine (82.0; 95% CI, 39-173; n=14) compared to those receiving two MCC-CRM (418; 95% CI, 325-537; n=82), two MCC-TT (277; 95% CI, 223-344; n=79) or MCC-TT followed by MCC-CRM (553; 95% CI, 322-949; n=18). The same group also had the lowest Hib geometric mean concentrations (0.60 μg/mL, 0.27-1.34) compared to 1.85 μg/mL (1.23-2.78), 2.86 μg/mL (2.02-4.05) and 4.26 μg/mL (1.94-9.36), respectively. Our results indicate that MCC vaccines with different carrier proteins are not interchangeable. When several MCC vaccines are available, children requiring more than one dose should receive MCC vaccines with the same carrier protein or, alternatively, receive MCC-TT first wherever possible.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carrier proteins; Conjugate vaccines; Interchangeability; Interference; Meningococcal capsular group C

Mesh:

Substances:

Year:  2014        PMID: 25510388     DOI: 10.1016/j.vaccine.2014.12.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?

Authors:  Helen Findlow; Ray Borrow
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.

Authors:  Tyler D Moeller; Kevin B Weyant; Matthew P DeLisa
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 3.  Interactions of conjugate vaccines and co-administered vaccines.

Authors:  H Findlow; R Borrow
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

4.  A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants.

Authors:  Christine Elizabeth Jones; Anna Calvert; Jo Southern; Mary Matheson; Nick Andrews; Asma Khalil; Hannah Cuthbertson; Bassam Hallis; Anna England; Paul T Heath; Elizabeth Miller
Journal:  BMC Med       Date:  2021-06-08       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.